aromatase Inhibitors (AIs)
Sponsors
Fudan University, Novartis Pharmaceuticals
Conditions
Breast CancerNeoplasms, Breast
Phase 2
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
NCT01924078
Start: 2010-10-31End: 2015-06-30Target: 100Updated: 2013-08-16
Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer
TerminatedNCT02213042
Start: 2014-10-24End: 2020-06-04Updated: 2021-10-13